SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 306,500 shares, a drop of 17.5% from the August 31st total of 371,600 shares. Based on an average daily volume of 35,900 shares, the short-interest ratio […]
Related Keywords
, Millennium Management , Hightower Advisors , Biotherapeutics Inc , Nasdaq , Biotherapeutics Company Profile , Citadel Advisors , Sab Biotherapeutics Inc , Renaissance Technologies , Get Free Report , Tower Advisors , State Street Corp , Street Corp , Sab Biotherapeutics , Nasdaq Sabs , Sabs , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.